These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 38691909)

  • 1. Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFR
    Fadaly WAA; Nemr MTM; Kahk NM
    Bioorg Chem; 2024 Jun; 147():107403. PubMed ID: 38691909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study.
    El Hamaky NFM; Hamdi A; Bayoumi WA; Elgazar AA; Nasr MNA
    Bioorg Chem; 2024 Jul; 148():107437. PubMed ID: 38749114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new cyclopropane sulfonamide derivatives as EGFR inhibitors to overcome C797S-mediated resistance and EGFR double mutation.
    Yao H; Ren Y; Wu F; Liu J; Li J; Cao L; Yan M; Li X
    Eur J Med Chem; 2024 Sep; 275():116590. PubMed ID: 38908104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Overcoming EGFR
    Zhang X; He J; Xu S; Fu L; Zheng P; Xu S; Pan Q; Zhu W
    ChemMedChem; 2024 May; 19(9):e202300634. PubMed ID: 38351876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors.
    Mahnashi MH; Nahari M; Almasoudi H; Alhasaniah A; Elgazwi S; Abou-Salim MA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2358934. PubMed ID: 38904116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase.
    Sebastian A; Abu Rabah RR; Zaraei SO; Vunnam S; Sultan S; Anbar HS; El-Gamal R; Tarazi H; Sarg N; Alhamad DW; Al Shamma SA; Shahin AI; Omar HA; Al-Tel TH; El-Gamal MI
    Eur J Med Chem; 2024 Aug; 274():116557. PubMed ID: 38850857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization.
    Ezelarab HAA; Ali TFS; Abbas SH; Sayed AM; Beshr EAM; Hassan HA
    Mol Divers; 2024 Apr; 28(2):563-580. PubMed ID: 36790582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer.
    Choudhary S; Doshi A; Luckett-Chastain L; Ihnat M; Hamel E; Mooberry SL; Gangjee A
    Bioorg Med Chem; 2021 Apr; 35():116061. PubMed ID: 33647840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment.
    Ryad N; Elmaaty AA; M Ibrahim I; Ahmed Maghrabi AH; Yahya Alahdal MA; Saleem RM; Zaki I; Ghany LMAA
    Future Med Chem; 2024; 16(11):1087-1107. PubMed ID: 38722235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies.
    Faizan S; Wali AF; Talath S; Rehman MU; Sivamani Y; Nilugal KC; Shivangere NB; Attia SM; Nadeem A; Elayaperumal S; Kumar BRP
    Eur J Med Chem; 2024 Sep; 275():116607. PubMed ID: 38908102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins.
    Du Y; Shi S; Shu C; He Y; Xu W; Wu D; Tian Y; Kong M; He J; Xie W; Qiu Y; Xu Y; Zou Y; Zhu Q
    Eur J Med Chem; 2024 Jun; 272():116489. PubMed ID: 38759458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of 5-amino-1H-pyrazole-4-carboxamide derivatives as pan-FGFR covalent inhibitors.
    Deng W; Chen X; Liang H; Song X; Xiang S; Guo J; Tu Z; Zhou Y; Chen Y; Lu X
    Eur J Med Chem; 2024 Sep; 275():116558. PubMed ID: 38870833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eco-friendly green synthesis of N‑pyrazole amino chitosan using PEG-400 as an anticancer agent against gastric cancer cells via inhibiting EGFR.
    Zhang L; Li C
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):365-373. PubMed ID: 38564118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme-1/cyclooxygenase-2 inhibitors: Design, synthesis, anti-hypertensive, anti-fibrotic, and anti-inflammatory.
    Fadaly WAA; Elshaier YAMM; Ali FEM; El-Bahrawy AH; Abdellatif KRA; Nemr MTM
    Drug Dev Res; 2024 Jun; 85(4):e22217. PubMed ID: 38845214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Analysis of the Macrocyclic Inhibitor BI-4020 Binding to EGFR Kinase.
    Beyett TS; Rana JK; Schaeffner IK; Heppner DE; Eck MJ
    ChemMedChem; 2024 Jun; 19(12):e202300343. PubMed ID: 38523074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor.
    Li H; Ke R; Zhou Y; Chang S; Wang J; Su C; Wu P; Yang B; Wang Z; Ding K; Ma D
    Eur J Med Chem; 2024 Jun; 272():116473. PubMed ID: 38718625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity.
    Abd El-Rahman YA; Chen PJ; ElHady AK; Chen SH; Lin HC; El-Gamil DS; Aboushady Y; Abadi AH; Engel M; Abdel-Halim M
    Future Med Chem; 2024; 16(12):1239-1254. PubMed ID: 38989990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potent and Selective Covalent Inhibitors of HER2
    Hicken EJ; Brown K; Dwulet NC; Gaudino JJ; Hansen EP; Hartley DP; Kowalski JP; Laird ER; Lazzara NC; Li B; Mou TC; Mutryn MF; Oko L; Pajk S; Pipal RW; Rosen RZ; Shelp R; Singh A; Wang J; Wise CE; Wong C; Wong JY
    J Med Chem; 2024 Jun; 67(11):9759-9771. PubMed ID: 38820338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-free, palladacycle-facilitated Suzuki coupling of hindered 2-arylbenzothiazole derivatives yields potent and selective COX-2 inhibitors.
    Elsayed MSA; Chang S; Cushman M
    Org Biomol Chem; 2017 Dec; 16(1):108-118. PubMed ID: 29199735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
    Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.